Grape molasses improved swallowing and appetite and reduced pain and fatigue in chemotherapy. Oral health 19. 01. 2022 Patients with head and neck cancer who used molasses from grapes during chemotherapy and radiotherapy, opened their mouths better and lost less weight than the control group, according to a study. Also, patients had better scores on functionality, emotional and social parameters, fatigue, appetite, and pain during chemotherapy and radiotherapy compared to the control group, which did not drink petimezi. According to the instructions, the patients gargled the grape molasses, twice a day, and then swallowed it, from the beginning of the radiotherapy to the end. They were told not eat anything for the next 15-20 minutes so as not to disrupt the coverage of the mucous membrane in the mouth by the grape molasses. The study evaluated 94 patients who received chemotherapy and radiotherapy for cancer of the head and neck. Nasopharyngeal cancer was the most common, followed by laryngeal and oral cancer and other types of tumors. Mucositis (stomatitis), mouth pain and weight loss were measured weekly. Sari SY et al. Do grapes and black mulberry molasses have an effect on oral mucositis and quality of life in patients with head and neck cancer? Supportive Care in Cancer 2022;30:327-336. Tags: radiotherapy , appetite , fatigue , stomatitis , chemotherapy
Ask our experts Quality of Life 25. 07. 2025 Do you have questions about your treatment?Click HERE to ask our experts for free.Are you starting, currently undergoing, or have you completed your cancer treatment?Are you concerned about side effec...[Read more]
Osteonecrosis of the Jaws in Cancer Medications Events, Seminars, & Publications 04. 11. 2025 Following the success of the mycancer Online Seminar Series, we are pleased to invite you to the 4th WEBINAR “Osteonecrosis of the Jaws in Cancer Medications” of the 2025 series.Our goal is to promote...[Read more]
Conference of the Hellenic Society of Head and Neck Cancer Events, Seminars, & Publications 18. 11. 2025 The Conference of the Hellenic Society of Head and Neck Cancer took place on 7–8 November 2025 at LAED in Athens with outstanding success, high participation, and a rich scientific program.The high q...[Read more]